Fusion energy requires a new commercial model. focusing on component technologies and creating a revenue bridge to fund ...

It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and ...

BMO Capital analyst Keith Tapper CFA has maintained their bullish stance on TSHA stock, giving a Buy rating today. Keith Tapper CFA’s ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

Researchers at Imperial College London, supported by colleagues at a range of other institutions, have published a study in ...

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing ...

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been completed in the optimization ...

Closed an Upsized and Oversubscribed $13 Million Public Offering to Fund Near-term Commercialization Milestones ...

Hera Biotech is developing a less invasive, more accurate diagnostic test for endometriosis, an often painful condition that ...

With today's rally, the nuclear energy stock is now up a whopping 38.6% so far this month after clocking a massive 65% gain ...

Insight is not something that can be gained merely through technical proficiency or the mastery of research methods.